Next Article in Journal
Stress-Activated Protein Kinases in Spinal Cord Injury: Focus on Roles of p38
Next Article in Special Issue
Angiotensin II-Induced Mesangial Cell Damage Is Preceded by Cell Membrane Permeabilization Due to Upregulation of Non-Selective Channels
Previous Article in Journal
miR-211 Plays a Critical Role in Cnidium officinale Makino Extract-Induced, ROS/ER Stress-Mediated Apoptosis in U937 and U266 Cells
Previous Article in Special Issue
TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in Mice
Open AccessReview

Role of Non-Myocyte Gap Junctions and Connexin Hemichannels in Cardiovascular Health and Disease: Novel Therapeutic Targets?

School of Biosciences and Medicine, University of Surrey, Guildford GU2 7XH, UK
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(3), 866; https://doi.org/10.3390/ijms19030866
Received: 10 February 2018 / Revised: 10 March 2018 / Accepted: 12 March 2018 / Published: 15 March 2018
The heart is a complex organ composed of multiple cell types, including cardiomyocytes and different non-myocyte populations, all working closely together to determine the hearts properties and maintain normal cardiac function. Connexins are abundantly expressed proteins that form plasma membrane hemichannels and gap junctions between cells. Gap junctions are intracellular channels that allow for communication between cells, and in the heart they play a crucial role in cardiac conduction by coupling adjacent cardiomyocytes. Connexins are expressed in both cardiomyocytes and non-myocytes, including cardiac fibroblasts, endothelial cells, and macrophages. Non-myocytes are the largest population of cells in the heart, and therefore it is important to consider what roles connexins, hemichannels, and gap junctions play in these cell types. The aim of this review is to provide insight into connexin-based signalling in non-myocytes during health and disease, and highlight how targeting these proteins could lead to the development of novel therapies. We conclude that connexins in non-myocytes contribute to arrhythmias and adverse ventricular remodelling following myocardial infarction, and are associated with the initiation and development of atherosclerosis. Therefore, therapeutic interventions targeting these connexins represent an exciting new research avenue with great potential. View Full-Text
Keywords: connexin; hemichannel; gap junction; cardiovascular disease; fibroblast; endothelial; macrophage; non-myocyte; therapeutic; inflammation connexin; hemichannel; gap junction; cardiovascular disease; fibroblast; endothelial; macrophage; non-myocyte; therapeutic; inflammation
Show Figures

Graphical abstract

MDPI and ACS Style

Johnson, R.D.; Camelliti, P. Role of Non-Myocyte Gap Junctions and Connexin Hemichannels in Cardiovascular Health and Disease: Novel Therapeutic Targets? Int. J. Mol. Sci. 2018, 19, 866.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop